Columbus McKinnon Corporation — Form 10-Q Summary
Reporting period: Three months ended June 30, 2023, representing fiscal 2024 first quarter. Results are unaudited and compared with the three months ended June 30, 2022. The company designs and manufactures intelligent motion, material-handling, crane, automation, and precision-conveyance solutions. Approximately 58% of quarterly sales were to U.S. customers and approximately 42% were generated outside the United States.
Financial performance and liquidity
| Metric | Q1 FY2024 | Q1 FY2023 | Change |
|---|---|---|---|
| Net sales | $235.5 million | $220.3 million | Up 6.9% |
| Gross profit | $86.6 million | $82.5 million | Up 5.0% |
| Gross margin | 36.8% | 37.5% | Down 70 bps |
| Income from operations | $21.4 million | $22.8 million | Down 6.0% |
| Operating margin | 9.1% | 10.4% | Down approximately 120 bps |
| Net income | $9.3 million | $8.4 million | Up 10.5% |
| Diluted EPS | $0.32 | $0.29 | Up $0.03 |
| Cash used in operating activities | $(17.2) million | $(11.2) million | Greater use of cash |
| Capital expenditures | $5.3 million | $3.0 million | Up $2.3 million |
- Sales growth reflected $8.5 million of price increases, $3.7 million of volume growth, $2.7 million of montratec revenue, and $0.3 million of favorable currency translation.
- Net income benefited from a lower effective tax rate of 27%, compared with 51% in the prior-year quarter. The prior-year rate was adversely affected by tax assessment settlements and a U.S. state valuation allowance.
- Cash, cash equivalents, and restricted cash declined to $107.2 million at June 30, 2023 from $133.4 million at March 31, 2023. Working capital absorbed $36.6 million of operating cash, primarily from higher inventory and receivables and lower accrued liabilities.
- Total reported debt and finance lease obligations were approximately $579.8 million, including $40.6 million classified as current. Cash less total reported debt and finance lease obligations was approximately negative $472.5 million, excluding marketable securities that are reserved for insurance claims.
- The company had $45.0 million drawn under its new accounts-receivable securitization facility, no revolver borrowings, and $15.8 million of letters of credit outstanding at quarter-end.
Material changes versus the prior comparable period
- Gross margin declined because of lower productivity, unfavorable sales mix, and business realignment costs, partially offset by pricing net of material inflation and montratec contributions.
- Operating income declined despite higher gross profit. General and administrative expense increased due to acquisition and deal costs, headquarters realignment costs, higher stock compensation, and montratec expenses.
- Interest and debt expense increased to $8.6 million from $6.2 million because of higher variable interest rates and additional acquisition-related borrowings.
- Net cash used for investing activities increased to $112.7 million, primarily reflecting $107.6 million paid for the acquisition of montratec GmbH and $5.3 million of capital expenditures.
- Financing activities provided $104.0 million, including $120.0 million of new long-term debt proceeds, partly offset by debt repayments, financing fees, and dividends.
- Product-group sales increased in Crane Solutions and Engineered Products, while Precision Conveyor Products declined. Industrial Products increased modestly.
Acquisition, outlook, risks, and unusual items
- On May 31, 2023, the company acquired montratec GmbH for $115.2 million, including $7.6 million of cash acquired. The preliminary allocation included $85.4 million of goodwill and $52.6 million of identifiable intangible assets. A contingent consideration liability of $25.1 million was recorded.
- Management expects fiscal 2024 capital expenditures of $30 million to $40 million and plans to make approximately $40 million of total principal payments over the next 12 months, compared with required Term Loan B payments of $6.1 million plus any required excess-cash-flow payments.
- The company estimates a fiscal 2024 effective tax rate of approximately 24% to 26% and believes available cash, operating cash flow, and borrowing capacity will fund operations, debt obligations, and capital expenditures for at least the next 12 months. This assessment depends on execution of the business plan and effective working-capital management.
- Management expects approximately $30 million of annual amortization expense based on current intangible assets and exchange rates. No goodwill impairment indicators were identified during the quarter.
- Key operating risks include cyclical industrial demand, acquisition integration, raw-material and component availability, inflation and pricing execution, interest rates, foreign exchange, debt covenant compliance, supply-chain dependence, product liability, environmental matters, cybersecurity, and international operations.
- Recorded contingencies include approximately $6.9 million of probable and estimable net asbestos liability, approximately $5.5 million of product-liability exposure, and $0.7 million of environmental liabilities. Management states that pending litigation and known environmental matters are not expected to materially affect liquidity or financial condition, although future charges could materially affect earnings.
- The company declared a quarterly dividend of $0.07 per share on July 23, 2023, expected to total approximately $2.0 million, payable August 21, 2023.
Important facts for investors to verify
- Whether montratec delivers the expected growth and margin contribution and whether the $25.1 million contingent consideration becomes payable.
- Progress in reducing leverage while funding planned capital expenditures and integration costs.
- Whether pricing continues to offset raw-material, freight, logistics, and productivity pressures.
- Working-capital normalization, particularly inventory and receivables, and the timing of a return to positive operating cash flow.
- Compliance with Term Loan B, revolver, and accounts-receivable securitization facility covenants and the impact of variable interest rates.
- Potential changes in asbestos, product-liability, tax, Monsanto-related, Italian tax, and environmental matters.
- The filing text contains an apparent fiscal-year reference inconsistency in MD&A regarding the tax-rate outlook; the financial-statement note identifies the 24%–26% estimate as applicable to fiscal 2024.